Preview Mode Links will not work in preview mode

Ridgeview and the Ridgeview Continuing Medical Education Program are proud to present the Ridgeview Podcast: CME Series; a quality, portable and on-demand continuing medical education, that features a variety of exceptional physicians, providers and other staff from Ridgeview and it's affiliates. Hosts of the program are Fred DeMeuse, PA-C, Jason Hicks, PA-C, and Leah Radde, RN. Thanks for tuning-in, downloading and listening! 

 

DISCLOSURE ANNOUNCEMENT 

The information provided through this and all Ridgeview podcasts as well as any and all accompanying files, images, videos and documents is/are for CME/CE and other institutional learning and communication purposes only and is/are not meant to substitute for the independent medical judgment of a physician, healthcare provider or other healthcare personnel relative to diagnostic and treatment options of a specific patient's medical condition; and are property/rights of Ridgeview & Ridgeview Clinics.  Any re-reproduction of any of the materials presented would be infringement of copyright laws. 

It is Ridgeview's intent that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts. It is not assumed any potential conflicts will have an adverse impact on these presentations. It remains for the audience to determine whether the speaker’s outside interest may reflect a possible bias, either the exposition or the conclusions presented.

Ridgeview's CME planning committee members and presenter(s) have disclosed they have no significant financial relationship with a pharmaceutical company and have disclosed that no conflict of interest exists with the presentation/educational event.

Jan 13, 2022

In this podcast, Dr. Laura Mohling, a pediatrician with Lakeview Clinic, talks about pathogens that infect children, childhood immunizations, current guidelines regarding vaccine scheduling, and vaccine hesitancy.

Enjoy the podcast!

Objectives:
  Upon completion of this podcast, participants should be able to:

  • Name at least 3 pathogens mentioned in the podcast children/adolescents were/are susceptible to.
  • Distinguish between the two different meningococcal vaccines available.
  • Summarize Human Papilloma Virus (HPV) recommendations for adolescents.

CME credit is only offered to Ridgeview Providers & Allied Health Staff for this podcast activity. Complete and submit the online evaluation form, after viewing the activity.  Upon successful completion of the evaluation, you will be e-mailed a certificate of completion within approximately 2 weeks. You may contact the accredited provider with questions regarding this program at  rmccredentialing@ridgeviewmedical.org.

To receive continuing education credit for this activity - click the link below, to complete the activity's evaluation.

CME Evaluation

(**If you are listening to the podcasts through iTunes on your laptop or desktop, it is not possible to link directly with the CME Evaluation for unclear reasons. We are trying to remedy this. You can, however, link to the survey through the Podcasts app on your Apple and other smart devices, as well as through Spotify, Stitcher and other podcast directory apps and on your computer browser at these websites. We apologize for the inconvenience.) 

DISCLOSURE ANNOUNCEMENT 

The information provided through this and all Ridgeview podcasts as well as any and all accompanying files, images, videos and documents is/are for CME/CE and other institutional learning and communication purposes only and is/are not meant to substitute for the independent medical judgment of a physician, healthcare provider or other healthcare personnel relative to diagnostic and treatment options of a specific patient's medical condition; and are property/rights of Ridgeview Medical Center & Clinics.  Any re-reproduction of any of the materials presented would be infringement of copyright laws. 

It is Ridgeview's intent that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts. It is not assumed any potential conflicts will have an adverse impact on these presentations. It remains for the audience to determine whether the speaker’s outside interest may reflect a possible bias, either the exposition or the conclusions presented.

Ridgeview's CME planning committee members and presenter(s) have disclosed they have no significant financial relationship with a pharmaceutical company and have disclosed that no conflict of interest exists with the presentation/educational event.

Thank-you for listening to the podcast.

SHOW NOTES
*See the attachment for the full chapter summaries. 

Vaccines
- Biggest impact on public health
- Vaccine safety continues to improve.
- No causation of autism from MMR or other vaccines. (Andrew Wakefield debunking, Thimerosal-free).
- ACIP Schedule for Childhood Immunization

Meningococcus
- Causation - Neisseria meningitidis
-
Incidence declining
- Case fatality approximately 15%, with 10-20% survivor have serious sequelae.
- Serogroups 
     - Serogroup B and C - most frequent cause of disease in U.S.
     - Meningitis type B accounts for about 1/3 of cases in adolescents.
     - Serogroup A is rare in U.S.
- Meningococcal Vaccine
     - Meningococcal B vaccines (Trumenba and Bexsero) developed in 2014.
     - Vaccine short duration of protection (1-2 years) based on antibody response
     - Trumenba (2 doses 6 mos apart) \ Bexero (2 doses at least 1 mo apart)
    - MenACWY vaccine in 2005 primary dose at age 11, booster at age 16.

HPV
- HPV vaccine is the cancer prevention vaccine!
- Statistics
- Vaccine - Gardasil 9
     - ACIP recommendation of vaccine at age 11 or 12
     - dosing schedule of HPV vaccine

COVID-19 (SARS-CoV2)
- Approved vaccine for age 12 and above. (Pfizer-BioNTech)
- RNA vaccines
- Antigentic target  - how the vaccine works
- Co-administering with other vaccines
- ACIP, UpToDate, FDA statements regarding vaccine in adolescents

*For links to reference materials please see the full show notes.